Health Care: Drugs

BioTime Inc (BTX: AMEX)

$3.8 n/a | n/a%
09/23/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 7.04M 5.24M 4.43M 3.92M
Cost of Sales 1.11M 837.05K 792.66K 434.27K
Gross Operating Profit 5.93M 4.41M 3.64M 3.48M
Selling, General, and Administrative Expenses 29.13M 17.56M 15.56M 10.37M
Research & Development 42.60M 37.53M 44.07M 18.12M
Operating Income before D & A (EBITDA) -65.81M -50.68M -55.99M -25.00M
Depreciation & Amortization 6.86M 8.68M 3.28M 3.07M
Interest Income 0.00 0.00 0.00 19.38K
Other Income - Net 3.53M -383.64K -204.06K -324.57K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -69.17M -59.75M -59.47M -28.38M
Interest Expense 340.00K 88.50K 578.00 0.00
Pre-Tax Income -69.51M -59.83M -59.47M -28.38M
Income Taxes -4.52M -7.38M -3.28M 0.00
Minority Interest -11.14M -7.37M -9.03M -3.88M
Net Income From Continuing Operations -58.13M -43.78M -52.91M -25.31M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -58.13M -43.78M -52.91M -25.31M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -46.99M -36.41M -43.88M -21.43M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-58.13M -43.78M -52.91M -25.31M
Preferred Dividends
Net Income Available To Common -58.55M -43.87M -52.91M -25.31M
Basic EPS from Continuing Ops. -0.59 -0.55 -0.81 -0.44
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.59 -0.55 -0.81 -0.44
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.59 -0.55 -0.81 -0.44
Basic Normalized Net Income/Share -0.59 -0.55 -0.81 -0.44
EPS fr Continuing Ops. -0.59 -0.55 -0.81 -0.44
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.59 -0.55 -0.81 -0.44
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.59 -0.55 -0.81 -0.44
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.59 -0.55 -0.81 -0.44
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with BTX

Latest BTX Headlines from TheStreet

More Financial News for BTX

Press Releases for BTX

See All Press Releases

Partner Headlines for BTX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter